Annual EBITDA:
-$146.31M+$42.96M(+22.70%)Summary
- As of today, ADPT annual EBITDA is -$146.31 million, with the most recent change of +$42.96 million (+22.70%) on December 31, 2024.
- During the last 3 years, ADPT annual EBITDA has risen by +$47.03 million (+24.33%).
- ADPT annual EBITDA is now -286.67% below its all-time high of -$37.84 million, reached on December 31, 2017.
Performance
ADPT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$14.70M+$35.23M(+171.56%)Summary
- As of today, ADPT quarterly EBITDA is $14.70 million, with the most recent change of +$35.23 million (+171.56%) on September 30, 2025.
- Over the past year, ADPT quarterly EBITDA has increased by +$42.54 million (+152.77%).
- ADPT quarterly EBITDA is now at all-time high.
Performance
ADPT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$60.01M+$42.54M(+41.48%)Summary
- As of today, ADPT TTM EBITDA is -$60.01 million, with the most recent change of +$42.54 million (+41.48%) on September 30, 2025.
- Over the past year, ADPT TTM EBITDA has increased by +$86.06 million (+58.92%).
- ADPT TTM EBITDA is now -413.51% below its all-time high of -$11.69 million, reached on March 31, 2018.
Performance
ADPT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ADPT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +22.7% | +152.8% | +58.9% |
| 3Y3 Years | +24.3% | +138.4% | +69.2% |
| 5Y5 Years | -107.2% | +143.2% | +51.0% |
ADPT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +24.3% | at high | +129.4% | at high | +69.2% |
| 5Y | 5-Year | -107.2% | +24.3% | at high | +126.1% | at high | +71.0% |
| All-Time | All-Time | -286.7% | +24.3% | at high | +126.1% | -413.5% | +71.0% |
ADPT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $14.70M(+171.6%) | -$60.01M(+41.5%) |
| Jun 2025 | - | -$20.53M(+17.4%) | -$102.56M(+11.9%) |
| Mar 2025 | - | -$24.87M(+15.1%) | -$116.45M(+13.8%) |
| Dec 2024 | -$146.31M(+22.7%) | -$29.30M(-5.2%) | -$135.13M(+7.5%) |
| Sep 2024 | - | -$27.85M(+19.1%) | -$146.07M(+9.6%) |
| Jun 2024 | - | -$34.43M(+20.9%) | -$161.56M(+3.5%) |
| Mar 2024 | - | -$43.55M(-8.2%) | -$167.47M(+3.7%) |
| Dec 2023 | -$189.27M(-8.0%) | -$40.25M(+7.1%) | -$173.88M(-4.9%) |
| Sep 2023 | - | -$43.34M(-7.4%) | -$165.73M(-3.2%) |
| Jun 2023 | - | -$40.34M(+19.3%) | -$160.62M(+3.1%) |
| Mar 2023 | - | -$49.97M(-55.7%) | -$165.78M(+3.6%) |
| Dec 2022 | -$175.21M(+9.4%) | -$32.10M(+16.0%) | -$172.04M(+11.7%) |
| Sep 2022 | - | -$38.22M(+16.0%) | -$194.92M(+6.0%) |
| Jun 2022 | - | -$45.50M(+19.1%) | -$207.30M(-0.2%) |
| Mar 2022 | - | -$56.22M(-2.3%) | -$206.90M(-10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$193.34M(-33.9%) | -$54.98M(-8.7%) | -$187.56M(-8.2%) |
| Sep 2021 | - | -$50.60M(-12.2%) | -$173.42M(-10.6%) |
| Jun 2021 | - | -$45.10M(-22.3%) | -$156.85M(-7.5%) |
| Mar 2021 | - | -$36.88M(+9.7%) | -$145.94M(-3.4%) |
| Dec 2020 | -$144.34M(-104.5%) | -$40.84M(-20.0%) | -$141.08M(-15.3%) |
| Sep 2020 | - | -$34.03M(+0.5%) | -$122.35M(-17.3%) |
| Jun 2020 | - | -$34.20M(-6.8%) | -$104.31M(-23.7%) |
| Mar 2020 | - | -$32.01M(-44.8%) | -$84.35M(-19.5%) |
| Dec 2019 | -$70.60M(-61.3%) | -$22.11M(-38.3%) | -$70.60M(-45.6%) |
| Sep 2019 | - | -$15.99M(-12.3%) | -$48.49M(-49.2%) |
| Jun 2019 | - | -$14.23M(+22.1%) | -$32.50M(-77.9%) |
| Mar 2019 | - | -$18.26M(-56.3%) | -$18.26M(-56.3%) |
| Dec 2018 | -$43.76M(-15.6%) | - | - |
| Mar 2018 | - | -$11.69M | -$11.69M |
| Dec 2017 | -$37.84M | - | - |
FAQ
- What is Adaptive Biotechnologies Corporation annual EBITDA?
- What is the all-time high annual EBITDA for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation annual EBITDA year-on-year change?
- What is Adaptive Biotechnologies Corporation quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation quarterly EBITDA year-on-year change?
- What is Adaptive Biotechnologies Corporation TTM EBITDA?
- What is the all-time high TTM EBITDA for Adaptive Biotechnologies Corporation?
- What is Adaptive Biotechnologies Corporation TTM EBITDA year-on-year change?
What is Adaptive Biotechnologies Corporation annual EBITDA?
The current annual EBITDA of ADPT is -$146.31M
What is the all-time high annual EBITDA for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high annual EBITDA is -$37.84M
What is Adaptive Biotechnologies Corporation annual EBITDA year-on-year change?
Over the past year, ADPT annual EBITDA has changed by +$42.96M (+22.70%)
What is Adaptive Biotechnologies Corporation quarterly EBITDA?
The current quarterly EBITDA of ADPT is $14.70M
What is the all-time high quarterly EBITDA for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high quarterly EBITDA is $14.70M
What is Adaptive Biotechnologies Corporation quarterly EBITDA year-on-year change?
Over the past year, ADPT quarterly EBITDA has changed by +$42.54M (+152.77%)
What is Adaptive Biotechnologies Corporation TTM EBITDA?
The current TTM EBITDA of ADPT is -$60.01M
What is the all-time high TTM EBITDA for Adaptive Biotechnologies Corporation?
Adaptive Biotechnologies Corporation all-time high TTM EBITDA is -$11.69M
What is Adaptive Biotechnologies Corporation TTM EBITDA year-on-year change?
Over the past year, ADPT TTM EBITDA has changed by +$86.06M (+58.92%)